Fundz

Cirius Therapeutics

Grand Rapids, Michigan, United States · Biotechnology, Healthcare

Cirius Therapeutics is a clinical-stage pharmaceutical company developing innovative therapies for diseases caused by insulin resistance including Type 2 Diabetes, the metabolic consequences of Obesity, and MASLD/MASH.

Key facts

Headquarters
Grand Rapids, Michigan, United States
Employees
2
Industries
Biotechnology, Healthcare
Status
Private
Website
ciriustx.com
LinkedIn
Company page

Recent activity at Cirius Therapeutics

Cirius Therapeutics funding history

DateRoundAmount
Oct 2025Seed$800K
Oct 2024Seed$1.0M
Aug 2024Venture$1.3M
May 2019Venture$7.5M
Aug 2018Venture$9.0M

Leadership

  • Elaine Sun, Director
  • Dennis Ph.D., Director
  • Robert M.D., Director
  • David Andel, Director
  • Nilesh Ph.D., Director
  • Michael Jandernoa, Director
  • Daniel Ph.D., Director
  • Baltera Bob, Executive Officer, Director

Verified email and direct lines for Cirius Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Employee benefit plans

Cirius Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Feb 2027.

Cirius Therapeutics in the news

Companies similar to Cirius Therapeutics

About Cirius Therapeutics: questions and answers

What does Cirius Therapeutics do?

Cirius Therapeutics is a clinical-stage pharmaceutical company developing innovative therapies for diseases caused by insulin resistance including Type 2 Diabetes, the metabolic consequences of Obesity, and MASLD/MASH.

Where is Cirius Therapeutics headquartered?

Cirius Therapeutics is headquartered in Grand Rapids, Michigan, United States.

How many employees does Cirius Therapeutics have?

Cirius Therapeutics has about 2 employees.

Has Cirius Therapeutics raised funding?

Yes. Fundz has recorded 5 funding events for Cirius Therapeutics. The most recent, Seed of $800K, was in Oct 2025.

What is the latest news on Cirius Therapeutics?

On Oct 08, 2025, Cirius Therapeutics

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Cirius Therapeutics across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.